Tradename: M-M-R II

Proper Name: Measles, Mumps, and Rubella Virus Vaccine Live

Indication: To include safety and immunogenicity data that support the intramuscular route as an additional route of administration for M-M-R II, and associated product labeling changes.

M-M-R II is a vaccine indicated for active immunization for the prevention of measles, mumps and rubella in individuals 12 months of age and older.  

Approval Date: 02/27/2023

Manufacturer: Merck Sharp & Dohme Corp.